Skip to main content
. 2020 Oct;8(19):1224. doi: 10.21037/atm-20-2141

Table 2. Patients information and visual outcomes.

Patient No. Eye Gender Age range, years SE (D) ADD (D) DCNVA (logMAR) DCIVA (logMAR) UDVA (logMAR)
Preop 6-month 12-month Preop 6-month 12-month Preop 6-month 12-month Δ12-month-pre Preop 6-month 12-month Δ12-month-pre Preop 6-month 12-month
1 OU Female 0.46 0.22 0.28 −0.18 0.34 0.00 0.10 −0.24 0.02 −0.10 −0.08
OS 0.50 0.50 0.50 2.50 1.25 1.25 0.54 0.28 0.30 −0.24 0.50 0.04 0.10 −0.40 0.04 −0.10 −0.10
OD 60−65 0.50 0.50 0.50 2.50 1.25 1.25 0.56 0.30 0.32 −0.24 0.50 0.14 0.16 −0.34 0.04 −0.06 −0.10
2 OU Female 0.32 0.08 0.14 −0.18 0.20 0.10 0.08 −0.12 −0.18 −0.26 −0.18
OS 0.13 0.13 0.13 2.25 1.25 1.25 0.46 0.30 0.30 −0.16 0.20 0.10 0.12 −0.08 −0.18 −0.24 −0.20
OD 50−55 0.00 0.00 0.00 2.25 1.00 1.00 0.44 0.24 0.38 −0.06 0.20 0.10 0.24 0.04 −0.16 −0.20 −0.20
3 OU Female 0.34 0.30 0.26 −0.08 0.28 0.08 0.02 −0.26 −0.10 −0.16 −0.18
OS −0.13 −0.13 −0.13 1.75 1.25 1.25 0.36 0.44 0.48 0.12 0.24 0.12 0.14 −0.10 0.02 0.00 −0.02
OD 55−60 0.13 0.13 0.13 2.25 1.25 1.25 0.42 0.34 0.48 0.06 0.42 0.04 0.08 −0.34 −0.06 −0.08 −0.10
4 OU Female 0.52 0.34 0.36 −0.16 0.48 0.28 0.30 −0.18 −0.12 −0.12 −0.10
OS 0.50 0.50 0.25 2.00 1.25 1.50 0.56 0.40 0.40 −0.16 0.48 0.32 0.32 −0.16 −0.12 −0.16 −0.14
OD 55−60 0.25 0.25 0.25 2.00 1.25 1.50 0.58 0.36 0.38 −0.20 0.50 0.32 0.42 −0.08 −0.14 −0.14 −0.12

SE, spherical equivalent refraction; ADD, the power of the near addition; DCNVA, distance corrected near visual acuity; DCIVA, distance corrected intermediate visual acuity.